Oseltamivir activity against avian influenza H9N2 strain with different point mutations in their neuraminidase
Taha Kumosani1, Diana Ahmadieh, Houssam Shaib
1Biochemistry Department, Faculty of Science and Experimental Biochemistry Unit, King Fahad Medical Research Center, King Abdul Aziz University, P.O. Box 80216, Jeddah, Saudi Arabia.
Abstract:
The present study has two aims: to optimize the antiviral activity of oseltamivir in chicken embryos against an avian influenza-H9N2 strain (P0) and to apply the optimized protocol for studying the drug susceptibility of 4 H9N2 mutants (M1, M2, M3, and M4). As for the first aim, oseltamivir antiviral activity was monitored upon its delivery into 9-day-old chicken embryo at a concentration of 0.27 mg/100 μl, against 7 doses of the P0 strain, ranging between 1.2 x 10(-5) and 2.0 Hemagglutination (HA) units. Oseltamivir showed its highest efficacy in reduction of viral propagation (95% reduction in HA titer) (P 〈0.05), when the inoculum level contained a minimum HA units of 1.2 x 10(-5). For the second aim of this study, the application of the 1.2 x 10-(5) HA units of the virus in inocula for the evaluation of oseltamivir-antiviral effect against the 4 H9N2 mutants revealed an emergence of a resistant mutant (M1), associated with 2 adjacent point mutations in its neuraminidase (N) amino acid (aa) sequence at positions 46 and 47. The other 3 mutants maintained a variable sensitivity to oseltamivir, resulting in the following reduction in HA titers: M2 (82.9%), M3 (61.5%), and M4 (100.0%). How the point mutations of the neuraminidase sequences affected the susceptibility of H9N2 virus to oseltamivir is still to be determined and deserve further investigations.
Insights
Oseltamivir effectively reduced avian influenza-H9N2 viral propagation in chicken embryos. However, one H9N2 mutant (M1) showed resistance due to neuraminidase mutations, highlighting evolving drug resistance in influenza viruses.
Area of Science:
- Virology
- Pharmacology
- Molecular Biology
Background:
- Avian influenza virus (AIV) poses a significant threat to poultry and public health.
- Oseltamivir is a key antiviral medication used to manage influenza infections.
- Understanding drug resistance mechanisms is crucial for effective antiviral therapy.
Purpose of the Study:
- To optimize oseltamivir delivery for maximum antiviral activity against avian influenza-H9N2 in chicken embryos.
- To assess the susceptibility of oseltamivir-treated H9N2 mutants to the drug.
- To investigate the impact of neuraminidase mutations on oseltamivir resistance.
Main Methods:
- Chicken embryo model used to test oseltamivir efficacy against avian influenza-H9N2 (P0 strain).
- Optimized oseltamivir concentration (0.27 mg/100 μl) and viral inoculum (1.2 x 10⁻⁵ HA units) determined.
- Susceptibility of four H9N2 mutants (M1-M4) to oseltamivir evaluated using the optimized protocol.
Main Results:
- Oseltamivir achieved a 95% reduction in viral propagation (HA titer) against the P0 strain at the optimized conditions.
- One mutant (M1) exhibited resistance to oseltamivir, showing minimal reduction in HA titer.
- Mutants M2, M3, and M4 displayed varying sensitivity, with HA titer reductions of 82.9%, 61.5%, and 100.0%, respectively.
- Mutant M1 resistance was linked to two adjacent point mutations in the neuraminidase (N) amino acid sequence (positions 46 and 47).
Conclusions:
- The study successfully optimized oseltamivir delivery in chicken embryos for avian influenza-H9N2.
- Emergence of oseltamivir-resistant H9N2 mutant (M1) identified, associated with specific neuraminidase mutations.
- Further research is needed to elucidate the precise mechanism by which neuraminidase mutations influence H9N2 susceptibility to oseltamivir.
More Related Videos
07:55Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
Published on: August 29, 2017
08:10Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
Published on: January 15, 2020
Related Concept Videos
Viral Mutations
Influenza
Leaky Scanning
